The malaria parasite Plasmodium falciparum is highly adapted to cope with the oxidative
stress to which it is exposed during the erythrocytic stages of its life cycle. This includes the …

Malaria in humans is caused by one of five species of obligate intracellular protozoan
parasites of the genus Plasmodium. P. falciparum causes the most severe disease and is …

Background Despite enormous efforts to combat malaria the disease still afflicts up to half a
billion people each year of which more than one million die. Currently no approved vaccine …

Malaria is one of the world's most common and serious diseases causing death of about 3
million people each year. Its most severe occurrence is caused by the protozoan …

Glutathione S‐transferase of the malarial parasite Plasmodium falciparum (PfGST)
represents a novel class of GST isoenzymes. Since the architecture of the PfGST substrate …

Malaria, leishmaniasis, Chagas disease, and human African trypanosomiasis continue to
cause considerable suffering and death in developing countries. Current treatment options …

Background Despite continuous efforts of the international community to reduce the impact
of malaria on developing countries, no significant progress has been made in the recent …

A cDNA clone coding for a mu‐class glutathione S‐transferase (GST) was isolated from a
hepatopancreas cDNA library from the shrimp Litopenaeus vannamei. The deduced amino …

Malaria represents an emerging disease because of increasing parasite resistance against
available drugs and because of increasing geographical distribution of the causative agent …

Malaria imposes a serious threat to human and becomes more prevalent due to the
emergence of drug resistant parasite. Understanding of the underlying mechanism of drug …